Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Atrial Appendage Occluder Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Atrial Appendage Occluder Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Valvular atrial fibrillation
      • 1.3.3 Non-valvular atrial fibrillation
    • 1.4 Market Segment by Application
      • 1.4.1 Global Atrial Appendage Occluder Market Share by Application (2019-2025)
      • 1.4.2 Clinics
      • 1.4.3 Hospitals
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Atrial Appendage Occluder Market Size
      • 2.1.1 Global Atrial Appendage Occluder Revenue 2014-2025
      • 2.1.2 Global Atrial Appendage Occluder Sales 2014-2025
    • 2.2 Atrial Appendage Occluder Growth Rate by Regions
      • 2.2.1 Global Atrial Appendage Occluder Sales by Regions 2014-2019
      • 2.2.2 Global Atrial Appendage Occluder Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Atrial Appendage Occluder Sales by Manufacturers
      • 3.1.1 Atrial Appendage Occluder Sales by Manufacturers 2014-2019
      • 3.1.2 Atrial Appendage Occluder Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Atrial Appendage Occluder Revenue by Manufacturers (2014-2019)
      • 3.2.2 Atrial Appendage Occluder Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Atrial Appendage Occluder Market Concentration Ratio (CR5 and HHI)
    • 3.3 Atrial Appendage Occluder Price by Manufacturers
    • 3.4 Key Manufacturers Atrial Appendage Occluder Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Atrial Appendage Occluder Market
    • 3.6 Key Manufacturers Atrial Appendage Occluder Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Valvular atrial fibrillation Sales and Revenue (2014-2019)
      • 4.1.2 Non-valvular atrial fibrillation Sales and Revenue (2014-2019)
    • 4.2 Global Atrial Appendage Occluder Sales Market Share by Type
    • 4.3 Global Atrial Appendage Occluder Revenue Market Share by Type
    • 4.4 Atrial Appendage Occluder Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Atrial Appendage Occluder Sales by Application

    6 United States

    • 6.1 United States Atrial Appendage Occluder Breakdown Data by Company
    • 6.2 United States Atrial Appendage Occluder Breakdown Data by Type
    • 6.3 United States Atrial Appendage Occluder Breakdown Data by Application

    7 European Union

    • 7.1 European Union Atrial Appendage Occluder Breakdown Data by Company
    • 7.2 European Union Atrial Appendage Occluder Breakdown Data by Type
    • 7.3 European Union Atrial Appendage Occluder Breakdown Data by Application

    8 China

    • 8.1 China Atrial Appendage Occluder Breakdown Data by Company
    • 8.2 China Atrial Appendage Occluder Breakdown Data by Type
    • 8.3 China Atrial Appendage Occluder Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Atrial Appendage Occluder Breakdown Data by Company
    • 9.2 Rest of World Atrial Appendage Occluder Breakdown Data by Type
    • 9.3 Rest of World Atrial Appendage Occluder Breakdown Data by Application
    • 9.4 Rest of World Atrial Appendage Occluder Breakdown Data by Countries
      • 9.4.1 Rest of World Atrial Appendage Occluder Sales by Countries
      • 9.4.2 Rest of World Atrial Appendage Occluder Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Boston Scientific
      • 10.1.1 Boston Scientific Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.1.4 Atrial Appendage Occluder Product Introduction
      • 10.1.5 Boston Scientific Recent Development
    • 10.2 SentreHEART Inc.
      • 10.2.1 SentreHEART Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.2.4 Atrial Appendage Occluder Product Introduction
      • 10.2.5 SentreHEART Inc. Recent Development
    • 10.3 Occlutech
      • 10.3.1 Occlutech Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.3.4 Atrial Appendage Occluder Product Introduction
      • 10.3.5 Occlutech Recent Development
    • 10.4 AtriCure
      • 10.4.1 AtriCure Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.4.4 Atrial Appendage Occluder Product Introduction
      • 10.4.5 AtriCure Recent Development
    • 10.5 Appriva Medical Inc.
      • 10.5.1 Appriva Medical Inc. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.5.4 Atrial Appendage Occluder Product Introduction
      • 10.5.5 Appriva Medical Inc. Recent Development
    • 10.6 St. Jude Medical
      • 10.6.1 St. Jude Medical Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.6.4 Atrial Appendage Occluder Product Introduction
      • 10.6.5 St. Jude Medical Recent Development
    • 10.7 PFM Medical Ag.
      • 10.7.1 PFM Medical Ag. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.7.4 Atrial Appendage Occluder Product Introduction
      • 10.7.5 PFM Medical Ag. Recent Development
    • 10.8 W. L. Gore & Associates
      • 10.8.1 W. L. Gore & Associates Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.8.4 Atrial Appendage Occluder Product Introduction
      • 10.8.5 W. L. Gore & Associates Recent Development
    • 10.9 Cardia, Inc.
      • 10.9.1 Cardia, Inc. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.9.4 Atrial Appendage Occluder Product Introduction
      • 10.9.5 Cardia, Inc. Recent Development
    • 10.10 Coherex Medical
      • 10.10.1 Coherex Medical Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Atrial Appendage Occluder
      • 10.10.4 Atrial Appendage Occluder Product Introduction
      • 10.10.5 Coherex Medical Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Atrial Appendage Occluder Sales Channels
      • 11.2.2 Atrial Appendage Occluder Distributors
    • 11.3 Atrial Appendage Occluder Customers

    12 Market Forecast

    • 12.1 Global Atrial Appendage Occluder Sales and Revenue Forecast 2019-2025
    • 12.2 Global Atrial Appendage Occluder Sales Forecast by Type
    • 12.3 Global Atrial Appendage Occluder Sales Forecast by Application
    • 12.4 Atrial Appendage Occluder Forecast by Regions
      • 12.4.1 Global Atrial Appendage Occluder Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Atrial Appendage Occluder Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Atrial Appendage Occluder is an ear shaped pouch present in the top left chamber of the human heart (Left Atrium). The functional significance of this structure is unknown. In patients living with arrhythmic cardiovascular conditions such as atrial fibrillation, blood accumulates in the left atrial appendage and can cause clotting of blood.
      Left atrial appendage closure is an implant-based alternative to blood thinners. Like blood thinning medications, an LAAC implant does not cure AF. A stroke can be due to factors not related to a clot traveling to the brain from the left atrium. Other causes of stroke can include high blood pressure and narrowing of the blood vessels to the brain. An LAAC implant will not prevent these other causes of stroke.
      In 2019, the market size of Atrial Appendage Occluder is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Atrial Appendage Occluder.

      This report studies the global market size of Atrial Appendage Occluder, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Atrial Appendage Occluder sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Boston Scientific
      SentreHEART Inc.
      Occlutech
      AtriCure
      Appriva Medical Inc.
      St. Jude Medical
      PFM Medical Ag.
      W. L. Gore & Associates
      Cardia, Inc.
      Coherex Medical

      Market Segment by Product Type
      Valvular atrial fibrillation
      Non-valvular atrial fibrillation

      Market Segment by Application
      Clinics
      Hospitals

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Atrial Appendage Occluder status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Atrial Appendage Occluder manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Atrial Appendage Occluder are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now